Response of serum angiotensin converting enzyme, plasma renin activity and plasma aldosterone to conventional dialysis in patients on chronic haemodialysis
- 1 July 1995
- journal article
- research article
- Published by Springer Nature in International Urology and Nephrology
- Vol. 27 (4) , 465-470
- https://doi.org/10.1007/bf02550085
Abstract
The aim of this study was to examine serum angiotensin converting enzyme (SACE) activity and the renin-angiotensin-aldosterone system in patients on chronic haemodialysis during one routine dialysis session. Fourteen patients (8 men and 6 women; mean age 51.9±17 years) with end stage renal disease, receiving regular haemodialysis treatment for an average of 6 months, were studied. The patients were dialysed for 4 hours three times a week using cellulose membranes (cuprophan). After an overnight fast blood samples were taken from the patients before and after the haemodialysis session. Serum and plasma were separated and stored at −20°C until assayed for SACE, plasma renin activity (PRA) and plasma aldosterone (PA). For comparison, SACE, PRA and PA were also measured in 8 patients after renal allotransplantation and on treatment with cyclosporin A (5 men, 3 women; mean age 38.9±12.3 years) and in 19 healthy subjects (13 men, 6 women; mean age 38.9±12.3 years). SACE levels in patients with chronic renal failure and on haemodialysis (17.55±9.03 nmol/ml/min) and in patients with renal transplantation (18.12±3.92) were significantly higher than those of the healthy subjects (9.27±1.67) (p<0.0001, respectively). At the end of the dialysis session SACE levels in patients with chronic renal failure (14.9±7.19) did not increase in respect to pre-dialysis levels (17.55±9.03; p=0.132). PRA and PA values increased after the dialysis session (p<0.026 and p<0.044, respectively). Correlation of SACE with PRA and PA was not demonstrated before or after the dialysis session. In patients with chronic renal failure and on haemodialysis our findings suggest that a disarrangement exists between the circulatory components of the renin-angiotensin-aldosterone system before and after the dialysis session.Keywords
This publication has 20 references indexed in Scilit:
- Angiotensin-converting enzyme activity in myocardial ischemia during exercise testingAmerican Heart Journal, 1993
- Angiotensin-Converting Enzyme Activity as a Prognostic Factor in Acute Renal FailureNephron, 1991
- Cyclosporin A treatment enhances angiotensin converting enzyme activity in lung and serum of ratsJournal of Pharmacy and Pharmacology, 1990
- Serum Angiotensin-Converting Enzyme Is Not an Indicator of Dialyzer Membrane BiocompatibilityNephron, 1988
- Serum Angiotensin-Converting Enzyme Increases during HemodialysisNephron, 1985
- Increased angiotensin-converting enzyme activities in diabetes mellitus: analysis of diabetes type, state of metabolic control and occurrence of diabetic vascular disease.Journal of Clinical Pathology, 1984
- Angiotensin-converting enzyme in diseases of the liverThe American Journal of Medicine, 1982
- Serum angiotensin converting enzyme activity in patients with chronic renal failure on long term hemodialysisClinica Chimica Acta; International Journal of Clinical Chemistry, 1979
- Elevation of Serum Angiotensin-Converting Enzyme in Gaucher's DiseaseNew England Journal of Medicine, 1976
- Angiotensin-Converting Enzyme and the Regulation of Vasoactive PeptidesAnnual Review of Biochemistry, 1976